ASXL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Patients with ASXL1 mutations were also younger and more frequently found in the high-risk category, suggesting a central role of clonal evolution associated with ASXL1 mutations in CML pathogenesis [31].